147 related articles for article (PubMed ID: 18329171)
21. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
22. Effect of mineral trioxide aggregate on rat clonal dental pulp cells: expression of cyclooxygenase-2 mRNA and inflammation-related protein via nuclear factor kappa B signaling system.
Minamikawa H; Deyama Y; Nakamura K; Yoshimura Y; Kaga M; Suzuki K; Yawaka Y
J Endod; 2009 Jun; 35(6):843-6. PubMed ID: 19482183
[TBL] [Abstract][Full Text] [Related]
23. Induction of heat shock protein 70 reduces the alteration of striatal electrical activity caused by mitochondrial impairment.
Tantucci M; Mariucci G; Taha E; Spaccatini C; Tozzi A; Luchetti E; Calabresi P; Ambrosini MV
Neuroscience; 2009 Oct; 163(3):735-40. PubMed ID: 19580850
[TBL] [Abstract][Full Text] [Related]
24. Signaling events leading to the curative effect of cystatin on experimental visceral leishmaniasis: involvement of ERK1/2, NF-kappaB and JAK/STAT pathways.
Kar S; Ukil A; Das PK
Eur J Immunol; 2009 Mar; 39(3):741-51. PubMed ID: 19197936
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease.
Napolitano M; Centonze D; Gubellini P; Rossi S; Spiezia S; Bernardi G; Gulino A; Calabresi P
Neurobiol Dis; 2004 Mar; 15(2):407-14. PubMed ID: 15006711
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological benefit of I(1)-imidazoline receptors activation and nuclear factor kappa-B (NF-κB) modulation in experimental Huntington's disease.
Gupta S; Sharma B
Brain Res Bull; 2014 Mar; 102():57-68. PubMed ID: 24582883
[TBL] [Abstract][Full Text] [Related]
27. Diclofenac enhances proinflammatory cytokine-induced nitric oxide production through NF-kappaB signaling in cultured astrocytes.
Kakita H; Aoyama M; Hussein MH; Kato S; Suzuki S; Ito T; Togari H; Asai K
Toxicol Appl Pharmacol; 2009 Jul; 238(1):56-63. PubMed ID: 19393675
[TBL] [Abstract][Full Text] [Related]
28. Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-kappaB pathways.
Jung WK; Choi I; Lee DY; Yea SS; Choi YH; Kim MM; Park SG; Seo SK; Lee SW; Lee CM; Park YM; Choi IW
Int J Biochem Cell Biol; 2008; 40(11):2572-82. PubMed ID: 18571461
[TBL] [Abstract][Full Text] [Related]
29. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
[TBL] [Abstract][Full Text] [Related]
30. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
[TBL] [Abstract][Full Text] [Related]
31. Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
Ryu JK; Choi HB; McLarnon JG
Neuroscience; 2006 Sep; 141(4):1835-48. PubMed ID: 16809003
[TBL] [Abstract][Full Text] [Related]
32. [The role for oxidative stress in neurodegenerative diseases].
Shibata N; Kobayashi M
Brain Nerve; 2008 Feb; 60(2):157-70. PubMed ID: 18306664
[TBL] [Abstract][Full Text] [Related]
33. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Dhir A; Akula KK; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
[TBL] [Abstract][Full Text] [Related]
34. Oxygen-induced mitochondrial biogenesis in the rat hippocampus.
Gutsaeva DR; Suliman HB; Carraway MS; Demchenko IT; Piantadosi CA
Neuroscience; 2006; 137(2):493-504. PubMed ID: 16298077
[TBL] [Abstract][Full Text] [Related]
35. 5-Chloroacetyl-2-amino-1,3-selenazoles attenuate microglial inflammatory responses through NF-kappaB inhibition.
Nam KN; Koketsu M; Lee EH
Eur J Pharmacol; 2008 Jul; 589(1-3):53-7. PubMed ID: 18538761
[TBL] [Abstract][Full Text] [Related]
36. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P
Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966
[TBL] [Abstract][Full Text] [Related]
37. Beta-catenin triggers nuclear factor kappaB-dependent up-regulation of hepatocyte inducible nitric oxide synthase.
Bandino A; Compagnone A; Bravoco V; Cravanzola C; Lomartire A; Rossetto C; Novo E; Cannito S; Valfrè di Bonzo L; Zamara E; Autelli R; Parola M; Colombatto S
Int J Biochem Cell Biol; 2008; 40(9):1861-71. PubMed ID: 18343708
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanism of manganese exposure-induced dopaminergic toxicity.
Prabhakaran K; Ghosh D; Chapman GD; Gunasekar PG
Brain Res Bull; 2008 Jul; 76(4):361-7. PubMed ID: 18502311
[TBL] [Abstract][Full Text] [Related]
39. Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.
Giampà C; DeMarch Z; D'Angelo V; Morello M; Martorana A; Sancesario G; Bernardi G; Fusco FR
Eur J Neurosci; 2006 Jan; 23(1):11-20. PubMed ID: 16420411
[TBL] [Abstract][Full Text] [Related]
40. Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages.
Kim BH; Hong SS; Kwon SW; Lee HY; Sung H; Lee IJ; Hwang BY; Song S; Lee CK; Chung D; Ahn B; Nam SY; Han SB; Kim Y
J Pharmacol Exp Ther; 2008 Nov; 327(2):393-401. PubMed ID: 18694995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
